Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Merck's Ditching of Aranesp Biosimilar Highlights Follow-on-Biologics Pitfalls
Merck's Ditching of Aranesp Biosimilar Highlights Follow-on-Biologics Pitfalls
Merck's Ditching of Aranesp Biosimilar Highlights Follow-on-Biologics Pitfalls
Submitted by
admin
on May 17, 2010 - 9:57am
Source:
Seeking Alpha
News Tags:
follow-on biologics
Aranesp
Merck
Amgen
Teva Pharmaceuticals
anemia
Headline:
Merck's Ditching of Aranesp Biosimilar Highlights Follow-on-Biologics Pitfalls
Do Not Allow Advertisers to Use My Personal information
